Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Assessment of the safety and the efficacy of a tacrolimus modified release (FK506MR) based
immunosuppressive regimen in stable kidney transplant subjects converted from a cyclosporin
based immunosuppressive regimen.